Follow
Steven W Goldstein
Steven W Goldstein
retired
No verified email
Title
Cited by
Cited by
Year
Novel thiazolidine-2, 4-diones as potent euglycemic agents.
B Hulin, DA Clark, SW Goldstein, RE McDermott, PJ Dambek, ...
Journal of medicinal chemistry 35 (10), 1853-1864, 1992
1271992
Structure of HIV-1 reverse transcriptase bound to an inhibitor active against mutant reverse transcriptases resistant to other nonnucleoside inhibitors
JD Pata, WG Stirtan, SW Goldstein, TA Steitz
Proceedings of the National Academy of Sciences 101 (29), 10548-10553, 2004
1152004
Substituted dihydrobenzopyran and dihydrobenzofuran thiazolidine-2, 4-diones as hypoglycemic agents
DA Clark, SW Goldstein, RA Volkmann, JF Eggler, GF Holland, B Hulin, ...
Journal of medicinal chemistry 34 (1), 319-325, 1991
1151991
The first enantioselective total syntheses of the allopumiliotoxin A alkaloids 267A and 339B
SW Goldstein, LE Overman, MH Rabinowitz
The Journal of Organic Chemistry 57 (4), 1179-1190, 1992
1021992
Synthetic studies of the cyclopropyl iminium ion rearrangement. 3. Application of the cyclopropyl acyliminium ion rearrangement to a concise and highly convergent synthesis of …
RK Boeckman, SW Goldstein, MA Walters
Journal of the American Chemical Society 110 (24), 8250-8252, 1988
881988
Synthetic studies of the cyclopropyl iminium ion rearrangement. 3. Application of the cyclopropyl acyliminium ion rearrangement to a concise and highly convergent synthesis of …
RK Boeckman, SW Goldstein, MA Walters
Journal of the American Chemical Society 110 (24), 8250-8252, 1988
881988
Discovery and optimization of a novel spiropyrrolidine inhibitor of β-secretase (BACE1) through fragment-based drug design
IV Efremov, FF Vajdos, KA Borzilleri, S Capetta, H Chen, PH Dorff, ...
Journal of medicinal chemistry 55 (21), 9069-9088, 2012
812012
CP-99,711: a non-peptide glucagon receptor antagonist
JL Collins, PJ Dambek, SW Goldstein, WS Faraci
Bioorganic & medicinal chemistry letters 2 (9), 915-918, 1992
661992
Thiazolidinedione hypoglycemic agents
DA Clark, SW Goldstein, GF Holland, B Hulin, JP Rizzi
US Patent 5,223,522, 1993
581993
Enantioselective total synthesis of allopumiliotoxin A alkaloids 267A and 339B
LE Overman, SW Goldstein
Journal of the American Chemical Society 106 (18), 5360-5361, 1984
581984
Hydroxyurea derivatives as hypoglycemic agents
SW Goldstein, RE McDermott, EM Gibbs, RW Stevenson
Journal of medicinal chemistry 36 (15), 2238-2240, 1993
511993
Thiazolidinedione hypoglycemic agents
DA Clark, SW Goldstein, GF Holland, B Hulin, JP Rizzi
US Patent 5,120,754, 1992
461992
Spiro hydantoin aldose reductase inhibitors derived from 8-aza-4-chromanones
R Sarges, SW Goldstein, WM Welch, AC Swindell, TW Siegel, TA Beyer
Journal of medicinal chemistry 33 (7), 1859-1865, 1990
461990
The total synthesis of macrocyclic lactones
RK Boeckman Jr, SW Goldstein
Total Synthesis of Natural Products 7, 1-139, 1988
461988
Thiazolidinedione hypoglycemic agents
DA Clark, SW Goldstein, GF Holland, B Hulin, JP Rizzi
US Patent 5,061,717, 1991
451991
Oxy substituted 4-carboxyamino-2-methyl-1, 2, 3, 4-tetrahydroquinolines
SW Goldstein, MR Makowski, RB Ruggeri, RT Wester
US Patent 6,140,342, 2000
442000
2-Substituted 1, 2, 3, 4-Tetrahydroquinolines from Quinoline
SW Goldstein, PJ Dambek
Synthesis 1989 (03), 221-222, 1989
431989
Oxa-and thiazolidinedione hypoglycemic and hypocholesterolemic agents
SW Goldstein
US Patent 5,037,842, 1991
411991
Hypoglycemic thiazolidinedione derivatives
DA Clark, SW Goldstein, B Hulin
US Patent 5,130,379, 1992
401992
Thiazolidinedione derivatives as hypoglycemic agents
DA Clark, SW Goldstein, B Hulin
US Patent 5,330,998, 1994
371994
The system can't perform the operation now. Try again later.
Articles 1–20